From Silence to Solutions: Urothelial Carcinoma in Dogs

Urothelial carcinoma, although rare, stands as the most prevalent cancer affecting the urinary tract in dogs, encompassing bladder and prostate cancer. Unfortunately, it often eludes detection until advanced stages, limiting treatment options and adversely affecting prognosis. Join us as we delve into the critical realm of early diagnosis for this challenging canine cancer, shedding light on the new non-invasive free-catch urine test capable of detecting the BRAF mutation associated with urothelial carcinoma. We will discuss strategies for identifying the disease's early signs and those who may be at heightened risk, underscoring the paramount importance of early detection in enhancing patient outcomes. Our presentation will not only explore early diagnosis but also highlight the latest breakthroughs in urothelial carcinoma treatment and management. We'll introduce a novel supplement with the potential to support our patients and improve their quality of life. This talk is designed to equip both seasoned veterinary professionals and aspiring students with the knowledge and tools to tackle urothelial carcinoma earlier and more effectively. Together, let's elevate our understanding of this complex disease, promote early detection, and strive for better outcomes in our furry companions. Presented by: Nutramax Laboratories Veterinary Sciences, Inc.